https://www.selleckchem.com/pr....oducts/anlotinib-al3
We found a remarkable difference of IC50 (τD) values in living cells and in solutions, suggesting it is quite necessary to evaluate the drug-target interactions in living cells. Compared with current methods, our approach can be used to in situ and real-time study the drug-target interaction in living cells, and it may become a promising and universal tool for in situ drug research at molecular level.In recent years, self-enhanced tris(bipyridine) ruthenium(II)-based luminescence systems have achieved great development in elect
Like
Comment
Share
